We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Hit With Lawsuit Over Cancer Drug Patent
Cabaret Biotech filed suit on Monday against Gilead and its Kite Pharma subsidiary alleging that Yescarta its CAR-T immunotherapy for non-Hodgkin’s lymphoma, infringed on its patent (7,741,465) targeting chimeric receptor genes.